The Food and Drug Administration (FDA) yesterday recalled 1.077 million Epilramate film-coated tablets after an inspection found that several batches of the medicine contained insufficient amounts of its main ingredient.
Two batches of Epilramate 25mg film-coated tablets (batch Nos. 190441 and 210466) and two batches of Epilramate 100mg film-coated tablets (batch Nos. 210467 and 210471) are to be withdrawn from the market, the agency said.
FDA medicinal product division specialist Hsu Chih-yu (許芷瑀) said that the main ingredient of the medicine is topiramate, which is primarily used for adjuvant treatment of partial epilepsy in adults and children over two, as well as epilepsy with Lennox-Gastaut syndrome or primary generalized tonic-clonic epilepsy.
Photo courtesy of the Food and Drug Administration
The medicine can be administered to treat people with partial-onset seizures or to prevent migraine.
“During the ongoing stability tests of the medicine, TWi Pharmaceuticals found that the amount of the main ingredient in the two types of tablets was 94 percent, below the 95 percent and 105 percent approved by FDA respectively,” Hsu said. “The impurities in the two types of tablets were 0.33 percent and 0.54 percent respectively, which also exceed the FDA standard of 0.25 percent.”
“As the medical effects might be compromised due to the errors, we have asked TWi Pharmaceuticals to recall the two types of tablets by Dec. 2,” she said.
Photo courtesy of the Food and Drug Administration
The National Health Insurance system last year covered the cost of 120,000 Epilramate 25mg tablets and 320,000 100mg tablets, its database showed.
TWi was also required to submit a report detailing the recall process as well as subsequent corrective measures, Hsu said.
Medical institutions and pharmacies across the nation should comply with the recall efforts, she said, adding that people who have taken the medicine should consult their doctors if they have doubts.
Separately, more than 80 percent of the medical institutions in the nation are expected to resume normal nuclear medicinal services this week following an emergency request to increase the domestic supply of technetium-99, the FDA said.
The global supply of technetium-99, a radioactive isotope commonly used in imaging, was disrupted by an unexpected mechanical failure of a BR2 nuclear reactor in Belgium last week. Due to a foreseeable shortage of the substance, hospitals have suspended or postponed exams in their nuclear medicinal departments.
FDA medicinal product section chief Yang Bo-wen (楊博文) said that technetium-99 is a key substance used in the imaging of the thyroid and salivary glands, as well as heterotopic gastric mucosa and tear ducts.
The government has issued permits to five suppliers to import the regulated substance. Three of the suppliers have reported supply shortages.
Yang said that it is difficult to gauge domestic demand for technetium-99, adding that the FDA has asked the importers to increase the supply of the substance.
SHIPS, TRAINS AND AUTOMOBILES: The ministry has announced changes to varied transportation industries taking effect soon, with a number of effects for passengers Beginning next month, the post office is canceling signature upon delivery and written inquiry services for international registered small packets in accordance with the new policy of the Universal Postal Union, the Ministry of Transportation and Communications said yesterday. The new policy does not apply to packets that are to be delivered to China, the ministry said. Senders of international registered small packets would receive a NT$10 rebate on postage if the packets are sent from Jan. 1 to March 31, it added. The ministry said that three other policies are also scheduled to take effect next month. International cruise ship operators
HORROR STORIES: One victim recounted not realizing they had been stabbed and seeing people bleeding, while another recalled breaking down in tears after fleeing A man on Friday died after he tried to fight the knife-wielding suspect who went on a stabbing spree near two of Taipei’s busiest metro stations, Taipei Mayor Chiang Wan-an (蔣萬安) said. The 57-year-old man, identified by his family name, Yu (余), encountered the suspect at Exit M7 of Taipei Main Station and immediately tried to stop him, but was fatally wounded and later died, Chiang said, calling the incident “heartbreaking.” Yu’s family would receive at least NT$5 million (US$158,584) in compensation through the Taipei Rapid Transit Corp’s (TRTC) insurance coverage, he said after convening an emergency security response meeting yesterday morning. National
PLANNED: The suspect visited the crime scene before the killings, seeking information on how to access the roof, and had extensively researched a 2014 stabbing incident The suspect in a stabbing attack that killed three people and injured 11 in Taipei on Friday had planned the assault and set fires at other locations earlier in the day, law enforcement officials said yesterday. National Police Agency (NPA) Director-General Chang Jung-hsin (張榮興) said the suspect, a 27-year-old man named Chang Wen (張文), began the attacks at 3:40pm, first setting off smoke bombs on a road, damaging cars and motorbikes. Earlier, Chang Wen set fire to a rental room where he was staying on Gongyuan Road in Zhongzheng District (中正), Chang Jung-hsin said. The suspect later threw smoke grenades near two exits
The Forestry and Nature Conservation Agency yesterday launched a gift box to market honey “certified by a Formosan black bear” in appreciation of a beekeeper’s amicable interaction with a honey-thieving bear. Beekeeper Chih Ming-chen (池明鎮) in January inspected his bee farm in Hualien County’s Jhuosi Township (卓溪) and found that more than 20 beehives had been destroyed and many hives were eaten, with bear droppings and paw prints near the destroyed hives, the agency said. Chih returned to the farm to move the remaining beehives away that evening when he encountered a Formosan black bear only 20m away, the agency said. The bear
RSS